ArticleNeuro-oncology advances
The Src inhibitor peptide TAT-Cx43
Abstract read
In one paragraph
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Pilar Cerveró-GarcíaInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0002-9812-9384
Enrique Jiménez-MadronaInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0002-9943-3564
Andrea Álvarez-VázquezInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0002-8626-8926
Raquel Flores-HernándezInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0003-4697-5180
Laura García-VicenteInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0001-8746-1050
Laura García-GuerreroInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0009-0008-3447-4104
Juan José Alonso-AmadorInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0009-0001-2367-6084
Raúl González-SánchezInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0009-0003-5219-7490
Claudia Ollauri-IbáñezInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0002-7319-4913
María Paniagua-SanchoInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0001-6981-4510
Rocío TalaverónInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0002-5068-9171
Telmo Rodrigues-TeixeiraCentro de Investigación del Cáncer (CIC), Servicio de Patología Molecular Comparada, Salamanca (T.R.-T.).ORCID https://orcid.org/0000-0002-3826-0997
Sandra M Martín-GuerreroBarts Cancer Institute, Queen Mary University of London, Londres (S.M.M.-G., P.C., V.R., T.S., P.R.C.).ORCID https://orcid.org/0000-0003-1489-4757
Pedro CasadoBarts Cancer Institute, Queen Mary University of London, Londres (S.M.M.-G., P.C., V.R., T.S., P.R.C.).ORCID https://orcid.org/0000-0002-4207-9349
Vinothini RajeeveBarts Cancer Institute, Queen Mary University of London, Londres (S.M.M.-G., P.C., V.R., T.S., P.R.C.).ORCID https://orcid.org/0000-0002-6361-4291
Tommy ShieldsBarts Cancer Institute, Queen Mary University of London, Londres (S.M.M.-G., P.C., V.R., T.S., P.R.C.).ORCID https://orcid.org/0009-0000-4198-3953
Maruan HijaziInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0003-0861-7577
Pedro R CutillasBarts Cancer Institute, Queen Mary University of London, Londres (S.M.M.-G., P.C., V.R., T.S., P.R.C.).ORCID https://orcid.org/0000-0002-3426-2274
Myriam Jaraíz-RodríguezInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0002-9908-3541
Arantxa TaberneroInstituto de Neurociencias de Castilla y León (INCyL), iBRAINS-IN-CyL, Dpt. Bioquímica y Biología Molecular, IBSAL, Universidad de Salamanca, Salamanca (P.C.-G., E.J.-M., A.A.-V., R.F.-H., L.G.-V., L.G.-G., J.J.A.-A., R.G.-S., C.O.-I., M.P.-S., R.T., M.H., M.J.-R., A.T.).ORCID https://orcid.org/0000-0001-6302-6134
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: TAT-Cx43 Methods: The effect of TAT-Cx43 Results: TAT-Cx43 Conclusions: Our results suggest that TAT-Cx43
Indexed as
brain metástasisconnexinCSCslung cancerSrc
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.